Fiche personne


Territoire

Bourgogne

Statut

Hospitalier

Équipes/plateformes

Département de Radiothérapie

Recherche

Expertises :
- Clinique:Radiothérapie

Projets


Publications


OLIGOPELVIS 2-GETUG P12- elective nodal radiotherapy for oligorecurrent pelvic/para-aortic nodes in prostate cancer: early toxicity of a randomized phase 3 trial.

Corda H, Blanc-Lapierre A, Pigne G, Cartier L, Pasquier D, Ronchin P, Bera G, Hasbini A, Schipman B, Khalifa J, Sargos P, Quivrin M, Schick U, Mallet F, Laude C, Morand C, Loos G, Vaugier L, Mesgouez-Nebout N, Supiot S

Radiother Oncol. 2027 04 9;:111533

Study Protocol of OLIGOPELVIS 2-GETUG P12: A Randomized Phase 3 Study Comparing Intermittent Androgen-deprivation Therapy with or Without Salvage High-dose Intensity-modulated Radiotherapy to Oligorecurrent Pelvic and Para-aortic Lymph Nodes in Patients w

Josset Q, Blanc-Lapierre A, Pigne G, Cartier L, Pasquier D, Ronchin P, Bera G, Hasbini A, Schipman B, Khalifa J, Sargos P, Quivrin M, Schick U, Mallet F, Laude C, Morand C, Loos G, Vaugier L, Zhou K, Mesgouez-Nebout N, Supiot S

Eur Urol Oncol. 2026 06 11;:

Radiotherapy with twice weekly Gemcitabine and Cisplatin compared to Cisplatin alone for organ preservation in muscle-invasive bladder cancer: results of the GETUG V04 randomized phase II trial.

Michalet M, Ronchin P, Reynaud T, Demogeot N, Gourgou S, Thézenas S, Hannoun-Lévi JM, Salem N, Quivrin M, Riou O, Charissoux M, Llacer-Moscardo C, Tosi D, Durdux C, Khalladi N, Culine S, Azria D

Radiother Oncol. 2026 02 12;217:111443

Voir plus